Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
16,679 results
- Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04786093).
- Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Durvalumab and Tremelimumab for Pediatric Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab for Pediatric Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03837899).
- Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435107).
- Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- DUS on the Prescribing Indications for CPA/EE in 5 European Countries: Complete Statistical AnalysisIndependent statistical analysis of DUS on the Prescribing Indications for CPA/EE in 5 European Countries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01231607).
- Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS: Complete Statistical AnalysisIndependent statistical analysis of Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DVIndependent statistical analysis of Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03242590).
- DW224-III-3Independent statistical analysis of A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DWETRIndependent statistical analysis of A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DYADIndependent statistical analysis of Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: Complete Statistical AnalysisIndependent statistical analysis of DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715452).
- Dymista Allergen Chamber – Onset of Action Study: Complete Statistical AnalysisIndependent statistical analysis of Dymista Allergen Chamber - Onset of Action Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04652245).
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation: Complete Statistical AnalysisIndependent statistical analysis of Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DYNAMOIndependent statistical analysis of A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dynasplint Therapy for Trismus in Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dynasplint Therapy for Trismus in Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00507208).
- DysmenorrheaIndependent statistical analysis of Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00517556).
- Dysport® Adult Upper Limb Spasticity Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Adult Upper Limb Spasticity Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313312).
- Dysport® Pediatric Lower Limb Spasticity Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Pediatric Lower Limb Spasticity Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251380).
- Dysregulation of FSH in Obesity: Functional and Statistical Analysis: Complete Statistical AnalysisIndependent statistical analysis of Dysregulation of FSH in Obesity: Functional and Statistical Analysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02478775).
- DYSTANCE 51Independent statistical analysis of Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DYVINIAIndependent statistical analysis of Dysport in Vulvodynia Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598777).
- E-3PTSDIndependent statistical analysis of Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-CAREIndependent statistical analysis of Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03863509).
- e-DomSantéIndependent statistical analysis of Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E-MomsIndependent statistical analysis of A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-SCAR DMDIndependent statistical analysis of Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01521546).
- E-TRaINIndependent statistical analysis of Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01426581).
- E-Visit for COPD and Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of E-Visit for COPD and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04155073).
- e۰Sense® Catheter Clinical Investigation: Complete Statistical AnalysisIndependent statistical analysis of e۰Sense® Catheter Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04438499).
- E3Independent statistical analysis of Adult Accuracy Study of the Enlite 3 Glucose Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02246582).
- E3 Breast Cancer Taxotere Combination: Complete Statistical AnalysisIndependent statistical analysis of E3 Breast Cancer Taxotere Combination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00494481).
- E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS): Complete Statistical AnalysisIndependent statistical analysis of E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence…
- E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- eACTIndependent statistical analysis of Epilepsy Adherence in Children and Technology (eACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03817229).
- EADCRAVIndependent statistical analysis of Enabling Advance Directive Completion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01746368).
- EAER21Independent statistical analysis of Validation of Indiana's Early Evaluation Hub System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06586788).
- EAISEIndependent statistical analysis of A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence…
- Ear Drops for Children With Otitis Media: Complete Statistical AnalysisIndependent statistical analysis of Ear Drops for Children With Otitis Media: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00622518).
- Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer: Complete Statistical AnalysisIndependent statistical analysis of Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer: primary endpoint results, effect estimate with confidence…
- Early Airway Response to Allergen in Asthmatics (MK-0000-176): Complete Statistical AnalysisIndependent statistical analysis of Early Airway Response to Allergen in Asthmatics (MK-0000-176): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061333).
- Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O): Complete Statistical AnalysisIndependent statistical analysis of Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639973).